William Niethammer
Fishers,IN
Summary
Dynamic technology leader in the biomedical diagnostics industry with over 10 years of specialized experience in oncology and pathology lab environments. Passionate problem solver who effectively bridges the gap between technical and scientific teams. Dedicated to enhancing patient care through innovative, right-sized solutions. Proven track record in building and managing high-performing, cross-functional teams that drive success and foster collaboration.
Overview
13
13
years of professional experience
Work History
Director of Product Development, Informatics
NeoGenomics Laboratories
11.2021 - Current
- Joined an emerging division within NeoGenomics focused on the curation and commercialization of genomic data. Adopted and re-tooled a team of product owners and software developers tasked with automating the curation and democratization of NeoGenomics' oncology datasets.
- Delivered Results:
- NeoSeek - Built a proprietary, self-service research portal to enable non-technical team members and clients to explore our data. Focused on cohort definition, patient screening, biomarker research, and the overlap of disparate datasets. This application is used daily by multiple internal teams and has been used by 12% of our clinical accounts.
- Data Abstraction - Built a proprietary data abstraction portal used to curate unstructured data elements for Neogenomics' data warehouse. This application has supported >$3.5M in revenue. Conducted proof-of-concept studies around the automation of data curation via OCR and NLP pipelines. Led two pilots with industry-specific vendors but ultimately decided to build our own due to cost and heterogeneity of our dataset.
- Data Curation - Created data repositories for whole slide images, remnant specimen material and NGS raw data files to improve oversight, archival, research, and commercialization of these assets.
- Data Acquisition - Implemented a Health Information Exchange data feed in partnership with a 3rd party vendor. This new data source provides clinical context about our patients and improves data fill rates for key elements used to stratify patient populations, optimize internal operations (reimbursement, etc.), and connect diagnostic testing, to treatment plans, and ultimately outcomes.
Director, Business Analysis
NeoGenomics Laboratories
12.2019 - 11.2021
- Product owner for the clinical division's software platforms, including our proprietary LIS/LIMS, NeoLINK. Directed a team of ten analysts in addition to guiding quality assurance and offshore development teams. Led efforts to rebuild team culture and SDLC processes.
- Delivered Results:.
- Process Improvements - Partnered with executive leaders and IBM consultants to develop new processes for collecting, evaluating and prioritizing all clinical projects. Established three scrum teams, retrospectives, work-from-home accommodations, and production support.
- Team Development - Recruited, developed, and championed a team of highly motivated analysts. Team achievements include numerous promotions, merit increases, individual contributor awards, and professional certifications.
- Laboratory Automation - Led teams and projects to improve throughput and accuracy, including NGS variant calling, automated NGS reporting, remote molecular signout, and specimen tracking.
- COVID-19 Testing - Rapidly developed in-house solutions enabling our COVID-19 laboratory to process >570K tests during the peak of the pandemic
Manager, Business Analysis
NeoGenomics Laboratories
03.2018 - 12.2019
- Led a growing team of business analysts responsible for all clinical division software development. Provided hands-on direction during project execution. Partnered with executive leadership to identify and deliver on key initiatives including the successful acquisition and integration of Genoptix.
- Delivered Results:
- Genoptix Acquisition - Directed the integration of people, processes, and systems over the course of 18 months, e.g., welcomed three analysts, consolidated test menus, and adapted/decommissioned redundant laboratory systems. National Promoter Score increased from 60 to 67 while retaining >95% of clients.
- NGS Reporting and Operational Overhaul - Managed the redesign of NeoGenomic's flagship multi-methodology profile, NeoTYPE, while refining wet and dry lab processes. Improved early, actionable biomarker reporting throughput by 400% via automated batch processing. Supported the internalization of bioinformatics pipelines and variant calling services resulting in an annual cost savings of over $900k.
- NeoCOMPLETE/COMPASS Product Launch - Provided project management and IT oversight on the creation and commercialization of a new multi-methodology hematological evaluation service. Enhanced system reporting capabilities to integrate the results of flow cytometry, morphology, cytogenetics, FISH, and molecular testing (including Sanger, PCR, and NGS).
Sr. Business Analyst
NeoGenomics Laboratories
06.2017 - 03.2018
- Product manager for anatomic pathology and molecular testing methodologies. Managed a team of analysts supporting the development and commercialization of new diagnostic offerings while implementing new tools to support unprecedented growth.
- Delivered Results:
- Pharmaceutical Systems and Site Implementation - Traveled to Rolle, Switzerland to assist in the validation and launch of the first international Pharma services laboratory. Focused on installing, validating, and training staff on digital pathology systems.
- Led efforts to implement a 21 CFR Pt. 11 compliant LIMS for the Pharmaceutical division. Responsible for the design, validation, and adoption of core components in LabVantage LIMS.
Business Systems Analyst
NeoGenomics Laboratories
04.2015 - 06.2017
- Relocated to California in order to support our largest laboratory, improve inter-departmental relations, and lead IT efforts during the acquisition of Clarient Diagnostics.
- Delivered Results:
- Clarient Diagnostics Acquisition - Primary systems analyst for acquisition of Clarient Diagnostics from GE Healthcare. Aligned people, process, and technology between two companies. Consolidated physical sites in Orange County.
- Digital Pathology Implementation - Product and implementation owner of proprietary whole slide image viewer. Managed the development and validation of the WSI platform including vendor management for scanning instrumentation and image analysis algorithms. Facilitated training and adoption for internal stakeholders and client pathologists.
- Recipient of the NeoGenomics' highest award, 'C.A.R.E', for excellent communication, accuracy, reliability, and efficiency.
Business Analyst
Chico's FAS Inc.
02.2013 - 04.2015
- Supported multiple SAP implementations and served as the lead analyst for data model consolidation including requirements definition, validation, and change management across downstream systems and cross-functional teams.
Education
Masters of Science - Biomedical Diagnostics
Arizona State University
12.2020
Bachelors of Science - Informatics
Indiana University
12.2012
Skills
- Strategic product planning
- Laboratory data management
- Experience in digital pathology applications
- Laboratory workflow optimization
- Employee talent development
- Turning ideas into action
Timeline
Director of Product Development, Informatics
NeoGenomics Laboratories
11.2021 - Current
Director, Business Analysis
NeoGenomics Laboratories
12.2019 - 11.2021
Manager, Business Analysis
NeoGenomics Laboratories
03.2018 - 12.2019
Sr. Business Analyst
NeoGenomics Laboratories
06.2017 - 03.2018
Business Systems Analyst
NeoGenomics Laboratories
04.2015 - 06.2017
Business Analyst
Chico's FAS Inc.
02.2013 - 04.2015
Bachelors of Science - Informatics
Indiana University
Masters of Science - Biomedical Diagnostics
Arizona State University